Targeting immunotherapy for bladder cancer using anti-CD3× B7-H3 bispecific antibody.

Wanru MaJuan MaPing MaTing LeiMan ZhaoMan Zhang

Published in: Cancer medicine (2018)

B7-H3 is an effective target for bladder cancer. B7-H3Bi-Ab enhances the ability of ATC to kill bladder cancer cells. B7-H3Bi-Ab-armed ATC is promisingly to provide a novel strategy for current bladder cancer therapy.

Keyphrases

cancer therapy
spinal cord injury
drug delivery
urinary tract
muscle invasive bladder cancer
nk cells